Related Experiment Video
Updated: Dec 8, 2025

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
Published on: March 17, 2012
Models of outpatient neuropalliative care for patients with amyotrophic lateral sclerosis
Joel N Phillips1, Jessica Besbris1, Laura A Foster1
1From the Mercy Health Hauenstein Neurosciences (J.N.P.), Trinity Health, Michigan State University, Grand Rapids; Department of Neurology (J.B.), Department of Supportive Care Medicine, Cedars-Sinai Medical Center, Los Angeles, CA; Department of Neurology (L.A.F.), University of Colorado, Aurora; Department of Medicine (Section of Palliative Medicine) (N.M.K.), Department of Neurology, Rush University Medical Center, Chicago, IL; Department of Neurology (S.M.), Department of Medicine (Palliative Division), Hennepin Healthcare, Minneapolis, MN; Palliative Care Program (A.K.M.), Department of Medicine, University of California, Los Angeles Health, CA; and Johns Hopkins Bayview Medical Center (A.K.M.), Baltimore, MD.
Objective:
To describe some current models of outpatient neuropalliative care (NPC) available to patients with amyotrophic lateral sclerosis at different institutions within the United States.
Methods:
Six NPC physicians were asked to contribute written descriptions about the PC available in their ALS clinics. Descriptions were then compiled and assessed for similarities and differences.
Results:
All clinics are multidisciplinary, with regular appointments every 3 months and similar appointment times for new visits (60-120 minutes) and follow-up visits (20-45 minutes). Four clinics have an NPC specialist embedded within the ALS clinic, 1 institution has a separate clinic for NPC, and 1 institution has both. The NPC physician at 5 institutions is a neurologist with formal palliative care training and at 1 institution is an internist with formal palliative care training. NPC is part of routine care for all patients at 2 institutions, and the primary reasons for consultation are goals of care (GOC) and severe symptom management.
Conclusion:
NPC is provided to patients with ALS heterogeneously throughout the United States with some variation in services and delivery, but all clinics are addressing similar core needs. Given the poor prognosis and high PC needs, those with ALS are the ideal patients to receive NPC. Future studies are necessary given the paucity of data available to determine best practices and to better define meaningful outcomes.
More Related Videos
10:49Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
Published on: September 18, 2011
07:00Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
Published on: October 13, 2016
Related Concept Videos
Parkinson's Disease: Overview
Peripheral Artery Disease III: Interprofessional Care
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Peripheral Artery Disease IV: Nursing Management
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...